GoldenGolden
Advanced Search
Fast Track Initiative

Fast Track Initiative

A venture capital firm in Tokyo that focuses on life sciences and healthcare services.

Fast Track Initiative is a venture capital firm in Tokyo that focuses on life sciences and healthcare services. Founded 2004 in Tokyo, Japan by Hiromichi Kimura, it invests in early stage ventures and seed. Its portfolio companies include Cytlimic, PuREC, Modalis Therapeutics, mediPhone, PENTAS,Mentalhealth Technologies, YUKASHIKADO, Braizon Therapeutics, Inc., Modulus Discovery, and RIN Institute. As of April 2020, Fast Track Initiative has made 23 investments. Their most recent investment was on August 9, 2019, when Cytlimic raised ¥1.3B. Fast Track Initiative has had one exit, which was CellSeed.

Timeline

2004
Founded

People

Name
Role
LinkedIn

Hiromichi Kimura Ph.D

Co-Founder, Managing Partner

Makoto Takeuchi

Senior Venture Expert

Masatoshi Sato

Venture Partner

Taku Nakahara Ph.D

Venture Expert

Tomohiro Anzai

COO & Managing Partner

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

Braizon Therapeutics, Inc.

Cytlimic

mediPhone

Mentalhealth Technologies

Modalis Therapeutics

Modulus Discovery

PENTAS

PuREC

YUKASHIKADO

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.